Tailored Health – Pharmacogenetics
An integrated approach to prescribing medication based on a patient’s genetics.
Project Budget* - $4.7M
Partner Co-investment - $2.7M
Supercluster Co-investment - $2.1M
Adverse reactions to medications account for up to 12 per cent of emergency room visits and 5 per cent of hospital admissions and are estimated to claim up to 22,000 lives per year in Canada.
This is exacerbated by the approximately 20 per cent of Canadians who currently take three or more medications (polypharmacy). As the Canadian population ages, the proportion of polypharmacy patients is expected to increase and cause additional stress on healthcare budgets.
Pharmacogenetics is the study of how genes affect a person’s response to drugs. Inappropriate medication prescribing is associated with adverse drug reactions, hospital admissions and mortality, which can all be reduced due to recent advances in genetic testing and translational technology.
Led by TELUS Health in partnership with GenXys, LifeLabs, Emily Carr University of Art + Design and Genome BC, the Tailored Health – Pharmacogenetics team is creating a pharmacogenetics ecosystem by digitally connecting testing labs and medication decision support software with primary care and pharmacy management systems.
Enabled by a digitally integrated solution, this project combines an individual’s genetic makeup with their biophysical, drug and medical history, integrating clinically useful medication options into the clinical workflow through electronic medical records and pharmacy management systems.
With patients and their clinicians using this solution, adverse drug reactions will be reduced, and the standard of care in Canada will be improved. The ultimate goal is to provide “the right drug to the right person at the right time.”